GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » Debt-to-Asset

OrbusNeich Medical Group Holdings (FRA:Q8T) Debt-to-Asset : 0.01 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is OrbusNeich Medical Group Holdings Debt-to-Asset?

OrbusNeich Medical Group Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €1.7 Mil. OrbusNeich Medical Group Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €2.3 Mil. OrbusNeich Medical Group Holdings's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was €411.6 Mil. OrbusNeich Medical Group Holdings's debt to asset for the quarter that ended in Dec. 2024 was 0.01.

OrbusNeich Medical Group Holdings Debt-to-Asset Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings Debt-to-Asset Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
Get a 7-Day Free Trial 0.50 0.25 0.01 0.02 0.01

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.02 0.02 0.01

Competitive Comparison of OrbusNeich Medical Group Holdings's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OrbusNeich Medical Group Holdings's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's Debt-to-Asset falls into.


;
;

OrbusNeich Medical Group Holdings Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

OrbusNeich Medical Group Holdings's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1.704 + 2.308) / 411.615
=0.01

OrbusNeich Medical Group Holdings's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1.704 + 2.308) / 411.615
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrbusNeich Medical Group Holdings  (FRA:Q8T) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

OrbusNeich Medical Group Holdings Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

OrbusNeich Medical Group Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » Debt-to-Asset
Comparable Companies
HKSE:03600 HKSE:01501 HKSE:01358 HKSE:01120 HKSE:01947 HKSE:01406 HKSE:00876 HKSE:08513 HKSE:01134 HKSE:00907 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM
Traded in Other Exchanges
06929:Hong Kong
Address
3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
Website
https://www.orbusneich.com
OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's majority revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

OrbusNeich Medical Group Holdings Headlines

No Headlines